IPA Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$7,475.33
Insider Selling (Last 12 Months): C$0.00

ImmunoPrecise Antibodies Insider Trading History Chart

This chart shows the insider buying and selling history at ImmunoPrecise Antibodies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ImmunoPrecise Antibodies Share Price & Price History

Current Price: C$0.00
Price Change: +0.30 (1.20%)
As of 10/25/2021 12:05 PM ET

This chart shows the closing price history over time for IPA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

SEC Filings (Institutional Ownership Changes) for ImmunoPrecise Antibodies (TSE:IPA)

ImmunoPrecise Antibodies logo
IPA is an innovation-driven, technology platform company that supports its pharmaceutical and biotechnology company partners in their quest to discover and develop novel, therapeutic antibodies against all classes of disease targets. The Company aims to transform the conventional, multi-vendor, product development model by bringing innovative and high-throughput, data-driven technologies to its partners, incorporating the advantages of diverse antibody repertoires with the Company's therapeutic antibody discovery suite of technologies, to exploit antibodies of broad epitope coverage, multiple antibody formats, valency and size, and to discover antibodies against multiple/rare epitopes.
Read More on ImmunoPrecise Antibodies

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies' top insider investors include:
  1. Dirk Witters (Director)
  2. Barry Alan Springer (Director)
  3. Ilse Roodink (Senior Officer)
  4. Jennifer Lynne Bath (Senior Officer)
  5. Kristin Taylor (Senior Officer)
  6. Mitchell Levine (Director)
Learn More about top insider investors at ImmunoPrecise Antibodies.